SlideShare une entreprise Scribd logo
1  sur  1
Identification of Fentanyl and Other Synthetic Opiates using Ambient Ionization
High Resolution Time-of-Flight Mass Spectrometry
Amanda Moore1
, Jamie Foss2,3
, Sabra Botch-Jones1
, Frank Kero3
1.Boston University School of Medicine, Boston, MA 2. Maine Health and Environmental Testing Laboratory, Augusta, ME 3. PerkinElmer, Shelton, CT
Fig 3. Glass capillary and mesh target screen sample trays for DSA (left). Schematic of DSA ionization
source (right).
Fig 2. (A) Close-up of mesh target screen sample tray and inlet to AxION TOF MS. (B) DSA
ionization source (C) DSA-TOF MS instrument.
A
B
CIntroduction
As of March 2016, the Drug Enforcement Administration placed
two fentanyl analogs (beta-hydroxythiofentanyl and butyryl
fentanyl) under Schedule I due to their imminent threat to public
health. These drugs elicit analgesic effects similar to heroin making
them desirable drugs to abuse. Novel fentanyl analogs and designer
opiates are expected to be more prominent in forensic casework in
the near future. These drugs can be seen in forensic casework either
alone or can be mixed with other drugs of abuse such as heroin. It is
therefore necessary to have an efficient methodology to identify
these compounds. Currently, Gas Chromatography-Mass
Spectrometry (GC-MS) is used to identify drugs of abuse and is
considered the “gold standard” in forensic casework. However,
analysis times can often range from 15-60 minutes in length.
Another drawback is need for spectral library matching, requiring
analytical reference materials for identification, meaning these new
designer drugs cannot be identified until a reference material is
available. In this study, Direct Sample Analysis Time-of-Flight
Mass Spectrometry (DSA-TOF) was utilized to provide rapid
identification of fentanyl and related synthetic opiates. DSA is a
direct ambient ionization source, requiring no chromatography and
minimal sample preparation. High resolution time of flight mass
spectrometry generates empirical formula information allowing for
substance identification without a reference material. Applying in-
source collision-induced dissociation (CID) produces additional
structural information for confirmation. The analytes explored in
this study include: heroin, 6-MAM, morphine, fentanyl,
norfentanyl, acetylfentanyl, butyrylfentanyl, beta-
hydroxythiofentanyl, furanylfentanyl, valerylfentanyl, AH-7921, U-
47700, buprenorphine, norbuprenorphine, desomorphine, MT-45,
W-15, and W-18.
Conclusion
•For the screening of synthetic opiates, DSA-TOF was successful at
reducing analysis time from minutes to seconds for qualitative
analyte identification.
• Analysis time was only 20 seconds.
•18 opiates and related compounds were evaluated, and in all
measurements, mass accuracy was below 5 ppm.
•In-source collision-induced dissociation (CID) can be used to
generate compound specific fragmentation for further
confirmation.
•Limit of detection (LOD) was determined to be 0.1 ppm. LOD was
determined by analyzing standards at 0.1 ppm, 0.05 ppm, and 0.01
ppm concentrations a minimum of 10 times. At 0.1 ppm, there was
only one mass accuracy failure, but no fragment identification
failure. At concentrations of 0.05 and 0.01 there was fragment
identification failure (signal below 500 counts) over 50% of the
time.
•Application of this method to a forensic case sample was successful,
demonstrating its utility in the forensic laboratory for these types of
compounds
•TOF allows for both targeted and non-targeted analysis
•As designer drugs emerge in communities, TOF methods allow the
flexibility to scale methods to include emerging public health
threats
•TOF allows the user to re-analyze sample data without the need for
reinjection
•Future Directions:
• Exploration of DSA-TOF MS as a rapid method to screen
urine samples for opiates
• DSA-TOF MS is currently being explored for use in the
identification of other street drugs.
Compound Formula Error (ppm)
Heroin C21H23NO5 0.387
6-MAM C19H21NO4 -4.44
Morphine C17H19NO3 -1.64
Buprenorphine C29H41NO4 -3.11
Norbuprenorphine C25H35NO4 -1.26
Fentanyl C22H28N2O -3.38
Norfentanyl C14H20N2O 4.71
Acetylfentanyl C21H26N2O -0.113
β-hydroxythiofentanyl C20H26N2O2S 1.73
Butyrylfentanyl C23H30N2O -1.3
Furanylfentanyl C24H26N2O2 0.529
Valerylfentanyl C24H32N2O -2.21
AH-7921 C16H22Cl2N2O -3.3
U-47700 C16H22Cl2N2O 0.819
Desomorphine C17H21NO2 -2.47
MT-45 C24H32N2 2.58
W-15 C19H21ClN2O2S -1.26
W-18 C19H20ClN3O4S -4.55
94.0631
105.0699
188.1445
189.1471
281.2007
337.2286
338.2318
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
100 200 300 400 500
Mass
GEN (00.09458:00.10791)
Amplitude
m/z
Curve 1
94.0405
105.0684
188.1437
189.1465
322.0484
323.2118
324.2150
0
5000
10000
15000
20000
25000
30000
35000
100 200 300 400 500
Mass
GEN (00.11150:00.12150)
Amplitude
m/z
Curve 1
94.0404
121.0497
188.1446
375.2065
376.2096
0
1000
2000
3000
4000
5000
6000
100 200 300 400 500
Mass
GEN (00.19458:00.20791)
Amplitude
m/z
Curve 1
105.0712
188.1455
189.1494
351.2435
352.2475
353.2532
0
5000
10000
15000
20000
25000
100 200 300 400 500
Mass
GEN (00.08116:00.09791)
Amplitude
m/z
Curve 1
94.0408
105.0438
121.0509
192.0862
210.0945
285.1418
341.1682
359.1782
360.1818
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000
100 200 300 400 500
Mass
GEN (00.19550:00.21216)
Amplitude
m/z
Curve 1
94.0416
121.0509
188.1445
189.1498
365.2596
366.2630
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
22000
100 200 300 400 500
Mass
GEN (00.14016:00.16016)
Amplitude
m/z
Curve 1
95.0856
172.9575
174.9546
189.9843 191.9820
284.0625
285.0667
286.0597
287.0611
329.1193
331.1169
0
5000
10000
15000
20000
25000
30000
35000
100 200 300 400 500
Mass
RET (00.13750)
Amplitude
m/z
Curve 1
94.0412
121.0509
167.1550
169.1699
181.1015
322.0456
350.2672
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
100 200 300 400 500
Mass
GEN (00.14541:00.15541)
Amplitude
m/z
Curve 1
94.0375
121.0509
174.9557
284.0606
285.0620
286.0578
287.0614
0
2000
4000
6000
8000
10000
12000
14000
16000
100 200 300 400 500
Mass
GEN (00.13783:00.14783)
Amplitude
m/z
Curve 1
273.0461
392.1215
394.1193
422.0955
423.0988
424.0933
0
1e4
2e4
3e4
4e4
5e4
6e4
7e4
8e4
9e4
10e4
100 200 300 400 500
Mass
RET (00.09308)
Amplitude
m/z
Curve 1
105.0710
121.0509 322.0459
377.1090
378.1108
379.1052
380.1089
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
100 200 300 400 500
Mass
RET (00.10908)
Amplitude
m/z
Curve 1
377.1090
378.1108
379.1052
380.1089
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
376 377 378 379 380 381 382
Mass
RET (00.10908)
Amplitude
m/z
Curve 1
Fig 4. Diagram of a TOF Mass Spectrometer showing the separation of ions of different mass (top).
Diagram of a TOF Mass Spectrometer showing how a Reflector improves mass resolution (bottom).
4 0 6 0 8 0 1 0 0 1 2 0 1 4 0 1 6 0 1 8 0 2 0 0 2 2 0 2 4 0 2 6 0 2 8 0 3 0 0 3 2 0 3 4 0 3 6 0 3 8 0 4 0 0 4 2 0 4 4 0
0
5 0 0 0 0
1 0 0 0 0 0
1 5 0 0 0 0
2 0 0 0 0 0
2 5 0 0 0 0
3 0 0 0 0 0
3 5 0 0 0 0
4 0 0 0 0 0
4 5 0 0 0 0
m / z - - >
A b u n d a n c e
S c a n 2 1 5 2 (1 6 .1 1 1 m in ) : 0 0 6 .D  d a ta .m s
2 8 3 . 1
2 4 0 . 1
9 5 . 1
1 5 8 . 14 2 . 2
1 8 7 . 1
3 7 2 . 11 2 8 . 1 3 3 1 . 1 4 0 5 . 2 4 4 5 . 9
4 0 6 0 8 0 1 0 0 1 2 0 1 4 0 1 6 0 1 8 0 2 0 0 2 2 0 2 4 0 2 6 0 2 8 0 3 0 0 3 2 0 3 4 0 3 6 0 3 8 0 4 0 0 4 2 0
0
1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
4 0 0 0 0
5 0 0 0 0
6 0 0 0 0
7 0 0 0 0
8 0 0 0 0
9 0 0 0 0
1 0 0 0 0 0
1 1 0 0 0 0
1 2 0 0 0 0
1 3 0 0 0 0
1 4 0 0 0 0
1 5 0 0 0 0
1 6 0 0 0 0
1 7 0 0 0 0
1 8 0 0 0 0
1 9 0 0 0 0
m / z - - >
A b u n d a n c e
S c a n 2 1 5 3 ( 1 6 .1 1 7 m i n ) : 0 1 0 C A Y M A N 0 4 7 5 9 9 3 - 3 4 .D  d a ta .m s
2 8 3 . 1
2 4 0 . 1
9 5 . 1
1 5 8 . 14 2 . 1
1 3 0 . 1 1 8 7 . 1
3 7 2 . 23 4 1 . 0 4 0 5 . 2
85.0280
105.0683
188.1441
189.1471
322.0487
325.1897
375.2069
376.2092
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
50000
55000
100 200 300 400 500
Mass
GEN (00.07450:00.08791)
Amplitude
m/z
Curve 1
375.2069
376.2092
377.2113
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
50000
55000
375 380 385 390
Mass
GEN (00.07450:00.08791)
Amplitude
m/z
Curve 1
Fig 1. NFLIS regional trends in fentanyl reported per 100,000 persons aged 15 or older, January
2009 – June 2014
Fig 5. DSA-TOF spectra at 10ppm concentration: a) fentanyl b) acetylfentanyl c)furanylfentanyl d) butyrylfentanyl e) β-
hydroxythiofentanyl f) valerylfentanyl g) AH-7921 h) MT-45 i) U-47700 j) W-18
Table 1. Molecular formula and mass accuracy for 18 compounds evaluated in this study.
IS
Mannitol
a
b
c
d
e
f
g
h
i
j
Acknowledgements
•Maria Pease, Maine HETL Forensic Chemistry Section
•Maine Drug Enforcement Agency
•David Francis, PerkinElmer, for troubleshooting assistance
•Charlie Schmidt and Bill Hahn for continued support
References
1.NATIONAL FORENSIC LABORATORY INFORMATION SYSTEM. Special Report:
Opiates and Related Drugs Reported in NFLIS, 2009–2014. Office of Diversion Control,
DOJ, DEA. 2015
2.Ohta, H.; Suzuki, S.; Ogasawara, K. Journal of Analytical Toxicology 1999, 23, 280–285.
3.Vardanyan, R.; Hruby, V.; Future Med Chem. 2014 March, 6(4), 385-412.
4.Winter, G.; Wilhide, J.; LaCourse, W.; J. Am. Soc. Mass Spectrom. 2015
5.PerkinElmer resources for AxION DSA-TOF
Instrumentation
PerkinElmer AxION 2 TOF Time of Flight Mass Spectrometer
PerkinElmer AxION Direct Sample Analysis module
Sample Preparation
Standard Solutions: 5 uL of dilute analytical standard was applied
directly to the mesh target screen for DSA-TOF analysis. Analytical
standards were purchase from Cerilliant Corporation (Round
Rock, TX) and Cayman Chemical (Ann Arbor, MI) at a
concentration of 1.0 mg/mL in methanol and diluted with LC-MS
Grade water (Sigma Aldrich).
Solid Samples: A small amount of sample was taken on the tip of a
spatula, added to 3 mL of Methanol and vortexed. 5 uL was applied
directly to the mesh target screen for DSA-TOF analysis.
AxION DSA/TOF MS Instrument Parameters
The AxION DSA conditions were as follows: a corona current of
5 µA, heater temperature of 325°C, auxiliary gas (N2) pressure of
80 psi, drying gas (N2) flow of 3 L/min, and drying gas (N2)
temperature of 25°C. The AxION 2 TOF MS was run in positive
mode with a flight tube voltage of -10,000 V. The capillary exit
voltage was set to 175V for MS analysis. Mass spectra were
acquired with a mass range of 85-2000 m/z and an acquisition rate
of 5 spectra/sec. To maintain mass accuracy, two lock mass ions
were used (m/z 121.0509 and m/z 622.0290). All samples were
analyzed for only 20 seconds.
Fig 6. DSA-TOF spectra of W-15 analytical standard (10 ppm). Fig 7. Close up of DSA-TOF spectra of W-15 [M+H]+
and isotopes.
Fig 8. AxION EC ID software determination of molecular formula for W-15 based on mass
accuracy, isotope ratios, and isotope spacing. Demonstration using analytical reference
material.
Fig 14. AxION EC ID software determination of molecular formula for unknown based on
mass accuracy, isotope ratios, and isotope spacing. Molecular formula for furanylfentanyl was
determined with a mass accuracy of -0.598 ppm. Following TOF analysis, an analytical
standard was run on GC-MS for confirmation.
Fig 9. TIC from GC-MS analysis of unknown substance.
Fig 10. EI-MS spectra of unknown (top). EI-MS spectra of Furanylfentanyl analytical standard (bottom).
Fig 12. DSA-TOF spectra of unknown sample. Fig 13. Close up of DSA-TOF spectra of unknown sample [M+H]+
and isotopes.
Fig 11. Unknown powder seized by law enforcement in Maine.
349.2629
[M+H]+
329.1179

Contenu connexe

Tendances

Illicit Drugs and Homemade Explosives Identification using FTIR Microscopy
Illicit Drugs and Homemade Explosives Identification using FTIR MicroscopyIllicit Drugs and Homemade Explosives Identification using FTIR Microscopy
Illicit Drugs and Homemade Explosives Identification using FTIR MicroscopyShimadzu Scientific Instruments
 
Overview of pharmaceutical analysis
Overview of pharmaceutical analysisOverview of pharmaceutical analysis
Overview of pharmaceutical analysiswashid84
 
2002 Pure Appl Chem Hill Conventional Analytical Methods Cwa
2002 Pure Appl Chem Hill Conventional Analytical Methods Cwa2002 Pure Appl Chem Hill Conventional Analytical Methods Cwa
2002 Pure Appl Chem Hill Conventional Analytical Methods Cwaguest971b1073
 
Pharmaceutics 03-00425
Pharmaceutics 03-00425Pharmaceutics 03-00425
Pharmaceutics 03-00425inscore
 
RP-HPLC Method Developed for the Estimation of Etodolac and Thiocolchicoside ...
RP-HPLC Method Developed for the Estimation of Etodolac and Thiocolchicoside ...RP-HPLC Method Developed for the Estimation of Etodolac and Thiocolchicoside ...
RP-HPLC Method Developed for the Estimation of Etodolac and Thiocolchicoside ...ijtsrd
 
Different techniques of analysis, Sources of impurities in medicinal agents.
Different techniques of analysis, Sources of impurities in medicinal agents.Different techniques of analysis, Sources of impurities in medicinal agents.
Different techniques of analysis, Sources of impurities in medicinal agents.Nidhi Sharma
 
Case Study: Sterilization of Surgical Instruments
Case Study: Sterilization of Surgical InstrumentsCase Study: Sterilization of Surgical Instruments
Case Study: Sterilization of Surgical InstrumentsJordi Labs
 
Using the US EPA's CompTox Chemistry Dashboard to advance non-targeted analys...
Using the US EPA's CompTox Chemistry Dashboard to advance non-targeted analys...Using the US EPA's CompTox Chemistry Dashboard to advance non-targeted analys...
Using the US EPA's CompTox Chemistry Dashboard to advance non-targeted analys...Andrew McEachran
 
Determination of % purity of a compound by by Using DSC
Determination of % purity of a compound by by Using DSCDetermination of % purity of a compound by by Using DSC
Determination of % purity of a compound by by Using DSCMUL
 
Anal BP102T-unit-1 intro for stu as per PCI syllabus
Anal BP102T-unit-1 intro for stu as per PCI syllabusAnal BP102T-unit-1 intro for stu as per PCI syllabus
Anal BP102T-unit-1 intro for stu as per PCI syllabusMonika Singh
 
Non biopsy diagnosis of acute rejection of Renal allograft
  Non biopsy diagnosis of acute rejection of Renal allograft  Non biopsy diagnosis of acute rejection of Renal allograft
Non biopsy diagnosis of acute rejection of Renal allograftBakshish Singh
 
Pharmaceutical analysis first
Pharmaceutical analysis first Pharmaceutical analysis first
Pharmaceutical analysis first dilshadAnsari11
 
Design and development of nanomaterials for biomolecular detection and cancer...
Design and development of nanomaterials for biomolecular detection and cancer...Design and development of nanomaterials for biomolecular detection and cancer...
Design and development of nanomaterials for biomolecular detection and cancer...Arun kumar
 
Application of nanomaterials in lifescience
Application of nanomaterials in lifescienceApplication of nanomaterials in lifescience
Application of nanomaterials in lifescienceArun kumar
 
High throughput screening (hts) copy
High throughput screening (hts)   copyHigh throughput screening (hts)   copy
High throughput screening (hts) copyIqrar Ansari
 

Tendances (20)

Etr1
Etr1Etr1
Etr1
 
Illicit Drugs and Homemade Explosives Identification using FTIR Microscopy
Illicit Drugs and Homemade Explosives Identification using FTIR MicroscopyIllicit Drugs and Homemade Explosives Identification using FTIR Microscopy
Illicit Drugs and Homemade Explosives Identification using FTIR Microscopy
 
3.1 Lovreglio
3.1 Lovreglio3.1 Lovreglio
3.1 Lovreglio
 
Overview of pharmaceutical analysis
Overview of pharmaceutical analysisOverview of pharmaceutical analysis
Overview of pharmaceutical analysis
 
2002 Pure Appl Chem Hill Conventional Analytical Methods Cwa
2002 Pure Appl Chem Hill Conventional Analytical Methods Cwa2002 Pure Appl Chem Hill Conventional Analytical Methods Cwa
2002 Pure Appl Chem Hill Conventional Analytical Methods Cwa
 
Pharmaceutics 03-00425
Pharmaceutics 03-00425Pharmaceutics 03-00425
Pharmaceutics 03-00425
 
RP-HPLC Method Developed for the Estimation of Etodolac and Thiocolchicoside ...
RP-HPLC Method Developed for the Estimation of Etodolac and Thiocolchicoside ...RP-HPLC Method Developed for the Estimation of Etodolac and Thiocolchicoside ...
RP-HPLC Method Developed for the Estimation of Etodolac and Thiocolchicoside ...
 
Different techniques of analysis, Sources of impurities in medicinal agents.
Different techniques of analysis, Sources of impurities in medicinal agents.Different techniques of analysis, Sources of impurities in medicinal agents.
Different techniques of analysis, Sources of impurities in medicinal agents.
 
Salomone 2017
Salomone 2017Salomone 2017
Salomone 2017
 
Case Study: Sterilization of Surgical Instruments
Case Study: Sterilization of Surgical InstrumentsCase Study: Sterilization of Surgical Instruments
Case Study: Sterilization of Surgical Instruments
 
Using the US EPA's CompTox Chemistry Dashboard to advance non-targeted analys...
Using the US EPA's CompTox Chemistry Dashboard to advance non-targeted analys...Using the US EPA's CompTox Chemistry Dashboard to advance non-targeted analys...
Using the US EPA's CompTox Chemistry Dashboard to advance non-targeted analys...
 
Determination of % purity of a compound by by Using DSC
Determination of % purity of a compound by by Using DSCDetermination of % purity of a compound by by Using DSC
Determination of % purity of a compound by by Using DSC
 
Advances in forensic chemistry
Advances in forensic chemistryAdvances in forensic chemistry
Advances in forensic chemistry
 
Why High-Throughput Screening Data quality is important: Ephrin pharmacophore...
Why High-Throughput Screening Data quality is important: Ephrin pharmacophore...Why High-Throughput Screening Data quality is important: Ephrin pharmacophore...
Why High-Throughput Screening Data quality is important: Ephrin pharmacophore...
 
Anal BP102T-unit-1 intro for stu as per PCI syllabus
Anal BP102T-unit-1 intro for stu as per PCI syllabusAnal BP102T-unit-1 intro for stu as per PCI syllabus
Anal BP102T-unit-1 intro for stu as per PCI syllabus
 
Non biopsy diagnosis of acute rejection of Renal allograft
  Non biopsy diagnosis of acute rejection of Renal allograft  Non biopsy diagnosis of acute rejection of Renal allograft
Non biopsy diagnosis of acute rejection of Renal allograft
 
Pharmaceutical analysis first
Pharmaceutical analysis first Pharmaceutical analysis first
Pharmaceutical analysis first
 
Design and development of nanomaterials for biomolecular detection and cancer...
Design and development of nanomaterials for biomolecular detection and cancer...Design and development of nanomaterials for biomolecular detection and cancer...
Design and development of nanomaterials for biomolecular detection and cancer...
 
Application of nanomaterials in lifescience
Application of nanomaterials in lifescienceApplication of nanomaterials in lifescience
Application of nanomaterials in lifescience
 
High throughput screening (hts) copy
High throughput screening (hts)   copyHigh throughput screening (hts)   copy
High throughput screening (hts) copy
 

En vedette

Microbiology Meets Mass Spectrometry
Microbiology Meets Mass SpectrometryMicrobiology Meets Mass Spectrometry
Microbiology Meets Mass SpectrometryMargie Morgan
 
Maldi tof ppt adnya
Maldi tof ppt adnyaMaldi tof ppt adnya
Maldi tof ppt adnyaAdnya Desai
 
MALDI-TOF: Pricinple and Its Application in Biochemistry and Biotechnology
MALDI-TOF: Pricinple  and Its Application in Biochemistry and BiotechnologyMALDI-TOF: Pricinple  and Its Application in Biochemistry and Biotechnology
MALDI-TOF: Pricinple and Its Application in Biochemistry and BiotechnologyDevakumar Jain
 
Mass spectrometry
Mass spectrometryMass spectrometry
Mass spectrometryarushe143
 
Toxicological Screening and Quantitation Using Liquid Chromatography/Time-of-...
Toxicological Screening and Quantitation Using Liquid Chromatography/Time-of-...Toxicological Screening and Quantitation Using Liquid Chromatography/Time-of-...
Toxicological Screening and Quantitation Using Liquid Chromatography/Time-of-...Annex Publishers
 
BITS - Introduction to Mass Spec data generation
BITS - Introduction to Mass Spec data generationBITS - Introduction to Mass Spec data generation
BITS - Introduction to Mass Spec data generationBITS
 
Mass spectrometry basic principles
Mass spectrometry basic principlesMass spectrometry basic principles
Mass spectrometry basic principlesRania Elsharkawy
 
QIAseq Technologies for Metagenomics and Microbiome NGS Library Prep
QIAseq Technologies for Metagenomics and Microbiome NGS Library PrepQIAseq Technologies for Metagenomics and Microbiome NGS Library Prep
QIAseq Technologies for Metagenomics and Microbiome NGS Library PrepQIAGEN
 
Mass Spectrometry Basic By Inam
Mass Spectrometry Basic By InamMass Spectrometry Basic By Inam
Mass Spectrometry Basic By InamInamul Hasan Madar
 
Multi-camera Time-of-Flight Systems | SIGGRAPH 2016
Multi-camera Time-of-Flight Systems | SIGGRAPH 2016Multi-camera Time-of-Flight Systems | SIGGRAPH 2016
Multi-camera Time-of-Flight Systems | SIGGRAPH 2016StanfordComputationalImaging
 
Mass spectrometry(Ionization Techniques) by Ashutosh Panke
Mass spectrometry(Ionization Techniques) by Ashutosh PankeMass spectrometry(Ionization Techniques) by Ashutosh Panke
Mass spectrometry(Ionization Techniques) by Ashutosh PankeAshutosh Panke
 
Reconnaissance de panneaux de signalisation routière en utilisant la détectio...
Reconnaissance de panneaux de signalisation routière en utilisant la détectio...Reconnaissance de panneaux de signalisation routière en utilisant la détectio...
Reconnaissance de panneaux de signalisation routière en utilisant la détectio...Loghin Dumitru
 
Les systèmes RADAR (CFAR)
Les systèmes RADAR (CFAR)Les systèmes RADAR (CFAR)
Les systèmes RADAR (CFAR)amsnet
 
PCR : Polymerase chain reaction : classique et en temps réel
PCR : Polymerase chain reaction : classique et en temps réelPCR : Polymerase chain reaction : classique et en temps réel
PCR : Polymerase chain reaction : classique et en temps réelNadia Terranti
 

En vedette (20)

Microbiology Meets Mass Spectrometry
Microbiology Meets Mass SpectrometryMicrobiology Meets Mass Spectrometry
Microbiology Meets Mass Spectrometry
 
Maldi tof ppt adnya
Maldi tof ppt adnyaMaldi tof ppt adnya
Maldi tof ppt adnya
 
MALDI-TOF: Pricinple and Its Application in Biochemistry and Biotechnology
MALDI-TOF: Pricinple  and Its Application in Biochemistry and BiotechnologyMALDI-TOF: Pricinple  and Its Application in Biochemistry and Biotechnology
MALDI-TOF: Pricinple and Its Application in Biochemistry and Biotechnology
 
Mass Spectrometry in Pharmacognosy
Mass Spectrometry in PharmacognosyMass Spectrometry in Pharmacognosy
Mass Spectrometry in Pharmacognosy
 
Mass spectrometry
Mass spectrometryMass spectrometry
Mass spectrometry
 
Toxicological Screening and Quantitation Using Liquid Chromatography/Time-of-...
Toxicological Screening and Quantitation Using Liquid Chromatography/Time-of-...Toxicological Screening and Quantitation Using Liquid Chromatography/Time-of-...
Toxicological Screening and Quantitation Using Liquid Chromatography/Time-of-...
 
BITS - Introduction to Mass Spec data generation
BITS - Introduction to Mass Spec data generationBITS - Introduction to Mass Spec data generation
BITS - Introduction to Mass Spec data generation
 
Mass spectrometry basic principles
Mass spectrometry basic principlesMass spectrometry basic principles
Mass spectrometry basic principles
 
QIAseq Technologies for Metagenomics and Microbiome NGS Library Prep
QIAseq Technologies for Metagenomics and Microbiome NGS Library PrepQIAseq Technologies for Metagenomics and Microbiome NGS Library Prep
QIAseq Technologies for Metagenomics and Microbiome NGS Library Prep
 
Ms basics
Ms basicsMs basics
Ms basics
 
Biotech 2012 spring-2-protein_chips
Biotech 2012 spring-2-protein_chipsBiotech 2012 spring-2-protein_chips
Biotech 2012 spring-2-protein_chips
 
Mass Spectrometry Basic By Inam
Mass Spectrometry Basic By InamMass Spectrometry Basic By Inam
Mass Spectrometry Basic By Inam
 
Multi-camera Time-of-Flight Systems | SIGGRAPH 2016
Multi-camera Time-of-Flight Systems | SIGGRAPH 2016Multi-camera Time-of-Flight Systems | SIGGRAPH 2016
Multi-camera Time-of-Flight Systems | SIGGRAPH 2016
 
Mass spectrometry(Ionization Techniques) by Ashutosh Panke
Mass spectrometry(Ionization Techniques) by Ashutosh PankeMass spectrometry(Ionization Techniques) by Ashutosh Panke
Mass spectrometry(Ionization Techniques) by Ashutosh Panke
 
Mass spectroscopy
Mass spectroscopyMass spectroscopy
Mass spectroscopy
 
Mass spectrometry
Mass spectrometryMass spectrometry
Mass spectrometry
 
Lc ms
Lc msLc ms
Lc ms
 
Reconnaissance de panneaux de signalisation routière en utilisant la détectio...
Reconnaissance de panneaux de signalisation routière en utilisant la détectio...Reconnaissance de panneaux de signalisation routière en utilisant la détectio...
Reconnaissance de panneaux de signalisation routière en utilisant la détectio...
 
Les systèmes RADAR (CFAR)
Les systèmes RADAR (CFAR)Les systèmes RADAR (CFAR)
Les systèmes RADAR (CFAR)
 
PCR : Polymerase chain reaction : classique et en temps réel
PCR : Polymerase chain reaction : classique et en temps réelPCR : Polymerase chain reaction : classique et en temps réel
PCR : Polymerase chain reaction : classique et en temps réel
 

Similaire à NEAFS_fentanyl poster

5-MEO-DALT produces short-lived psychedelic effects
5-MEO-DALT produces short-lived psychedelic effects5-MEO-DALT produces short-lived psychedelic effects
5-MEO-DALT produces short-lived psychedelic effectsBRC SHOP
 
The Expanding Reach of the Designer Drug Movement in 2011: Challenges for For...
The Expanding Reach of the Designer Drug Movement in 2011: Challenges for For...The Expanding Reach of the Designer Drug Movement in 2011: Challenges for For...
The Expanding Reach of the Designer Drug Movement in 2011: Challenges for For...NMS Labs
 
System suitability parameters assessment by HPLC
System suitability parameters assessment by HPLCSystem suitability parameters assessment by HPLC
System suitability parameters assessment by HPLCAnirban Barik
 
DETECTION_OF_TOXIC_ALKOLOIDS_BY_LC-MS
DETECTION_OF_TOXIC_ALKOLOIDS_BY_LC-MSDETECTION_OF_TOXIC_ALKOLOIDS_BY_LC-MS
DETECTION_OF_TOXIC_ALKOLOIDS_BY_LC-MSNial Harding
 
Flow Cytometry Multiplexing Used to Analyze Metabolic Activity and Assess Pha...
Flow Cytometry Multiplexing Used to Analyze Metabolic Activity and Assess Pha...Flow Cytometry Multiplexing Used to Analyze Metabolic Activity and Assess Pha...
Flow Cytometry Multiplexing Used to Analyze Metabolic Activity and Assess Pha...Thermo Fisher Scientific
 
Guidance Document for Acute Lethality Testing.PDF
Guidance Document for Acute Lethality Testing.PDFGuidance Document for Acute Lethality Testing.PDF
Guidance Document for Acute Lethality Testing.PDFGuy Gilron
 
Impurities profiling of ATZ
Impurities profiling of ATZImpurities profiling of ATZ
Impurities profiling of ATZNirav Soni
 
9 lattanzio myco_key_ws_multi-mycotoxin_screening
9 lattanzio myco_key_ws_multi-mycotoxin_screening9 lattanzio myco_key_ws_multi-mycotoxin_screening
9 lattanzio myco_key_ws_multi-mycotoxin_screeningISPA-CNR
 
Identification Of Fentanyl-Type Opioids Using GC-MS Fragmentation Data
Identification Of Fentanyl-Type Opioids Using GC-MS Fragmentation DataIdentification Of Fentanyl-Type Opioids Using GC-MS Fragmentation Data
Identification Of Fentanyl-Type Opioids Using GC-MS Fragmentation DataSteven Augustin
 
Comparison of Formulation Analysis by UPLC FINAL
Comparison of Formulation Analysis by UPLC FINALComparison of Formulation Analysis by UPLC FINAL
Comparison of Formulation Analysis by UPLC FINALJessica Sitko
 
Chromatographic Analysis of Pharmaceuticals Second Edition by John A. Adamovics
Chromatographic Analysis of Pharmaceuticals Second Edition by John A. AdamovicsChromatographic Analysis of Pharmaceuticals Second Edition by John A. Adamovics
Chromatographic Analysis of Pharmaceuticals Second Edition by John A. AdamovicsRohit K.
 
Research Project Dissertation_Final_270815_DT
Research Project Dissertation_Final_270815_DTResearch Project Dissertation_Final_270815_DT
Research Project Dissertation_Final_270815_DTDominic Thum
 
Analysis of pharmaceutical creams: a useful approach based on solid phase ext...
Analysis of pharmaceutical creams: a useful approach based on solid phase ext...Analysis of pharmaceutical creams: a useful approach based on solid phase ext...
Analysis of pharmaceutical creams: a useful approach based on solid phase ext...Ellen Bastos
 
Chemometrics Analysis and It's application in Herbal Drugs.pptx
Chemometrics Analysis and It's application in Herbal Drugs.pptxChemometrics Analysis and It's application in Herbal Drugs.pptx
Chemometrics Analysis and It's application in Herbal Drugs.pptxkaminiChaturvedi
 
Supercritical fluid (CO2) chromatography for quantitative determination of se...
Supercritical fluid (CO2) chromatography for quantitative determination of se...Supercritical fluid (CO2) chromatography for quantitative determination of se...
Supercritical fluid (CO2) chromatography for quantitative determination of se...Ratnakaram Venkata Nadh
 
Dissolution test.
Dissolution test.Dissolution test.
Dissolution test.Salum Mkata
 

Similaire à NEAFS_fentanyl poster (20)

5-MEO-DALT produces short-lived psychedelic effects
5-MEO-DALT produces short-lived psychedelic effects5-MEO-DALT produces short-lived psychedelic effects
5-MEO-DALT produces short-lived psychedelic effects
 
The Expanding Reach of the Designer Drug Movement in 2011: Challenges for For...
The Expanding Reach of the Designer Drug Movement in 2011: Challenges for For...The Expanding Reach of the Designer Drug Movement in 2011: Challenges for For...
The Expanding Reach of the Designer Drug Movement in 2011: Challenges for For...
 
System suitability parameters assessment by HPLC
System suitability parameters assessment by HPLCSystem suitability parameters assessment by HPLC
System suitability parameters assessment by HPLC
 
DETECTION_OF_TOXIC_ALKOLOIDS_BY_LC-MS
DETECTION_OF_TOXIC_ALKOLOIDS_BY_LC-MSDETECTION_OF_TOXIC_ALKOLOIDS_BY_LC-MS
DETECTION_OF_TOXIC_ALKOLOIDS_BY_LC-MS
 
Flow Cytometry Multiplexing Used to Analyze Metabolic Activity and Assess Pha...
Flow Cytometry Multiplexing Used to Analyze Metabolic Activity and Assess Pha...Flow Cytometry Multiplexing Used to Analyze Metabolic Activity and Assess Pha...
Flow Cytometry Multiplexing Used to Analyze Metabolic Activity and Assess Pha...
 
Guidance Document for Acute Lethality Testing.PDF
Guidance Document for Acute Lethality Testing.PDFGuidance Document for Acute Lethality Testing.PDF
Guidance Document for Acute Lethality Testing.PDF
 
E0412020025
E0412020025E0412020025
E0412020025
 
Impurities profiling of ATZ
Impurities profiling of ATZImpurities profiling of ATZ
Impurities profiling of ATZ
 
9 lattanzio myco_key_ws_multi-mycotoxin_screening
9 lattanzio myco_key_ws_multi-mycotoxin_screening9 lattanzio myco_key_ws_multi-mycotoxin_screening
9 lattanzio myco_key_ws_multi-mycotoxin_screening
 
Identification Of Fentanyl-Type Opioids Using GC-MS Fragmentation Data
Identification Of Fentanyl-Type Opioids Using GC-MS Fragmentation DataIdentification Of Fentanyl-Type Opioids Using GC-MS Fragmentation Data
Identification Of Fentanyl-Type Opioids Using GC-MS Fragmentation Data
 
Comparison of Formulation Analysis by UPLC FINAL
Comparison of Formulation Analysis by UPLC FINALComparison of Formulation Analysis by UPLC FINAL
Comparison of Formulation Analysis by UPLC FINAL
 
Chromatographic Analysis of Pharmaceuticals Second Edition by John A. Adamovics
Chromatographic Analysis of Pharmaceuticals Second Edition by John A. AdamovicsChromatographic Analysis of Pharmaceuticals Second Edition by John A. Adamovics
Chromatographic Analysis of Pharmaceuticals Second Edition by John A. Adamovics
 
2016 AGT Poster
2016 AGT Poster2016 AGT Poster
2016 AGT Poster
 
Research Project Dissertation_Final_270815_DT
Research Project Dissertation_Final_270815_DTResearch Project Dissertation_Final_270815_DT
Research Project Dissertation_Final_270815_DT
 
Analysis of pharmaceutical creams: a useful approach based on solid phase ext...
Analysis of pharmaceutical creams: a useful approach based on solid phase ext...Analysis of pharmaceutical creams: a useful approach based on solid phase ext...
Analysis of pharmaceutical creams: a useful approach based on solid phase ext...
 
Chemometrics Analysis and It's application in Herbal Drugs.pptx
Chemometrics Analysis and It's application in Herbal Drugs.pptxChemometrics Analysis and It's application in Herbal Drugs.pptx
Chemometrics Analysis and It's application in Herbal Drugs.pptx
 
Supercritical fluid (CO2) chromatography for quantitative determination of se...
Supercritical fluid (CO2) chromatography for quantitative determination of se...Supercritical fluid (CO2) chromatography for quantitative determination of se...
Supercritical fluid (CO2) chromatography for quantitative determination of se...
 
E0552228
E0552228E0552228
E0552228
 
Dissolution test.
Dissolution test.Dissolution test.
Dissolution test.
 
SIMR Poster
SIMR PosterSIMR Poster
SIMR Poster
 

NEAFS_fentanyl poster

  • 1. Identification of Fentanyl and Other Synthetic Opiates using Ambient Ionization High Resolution Time-of-Flight Mass Spectrometry Amanda Moore1 , Jamie Foss2,3 , Sabra Botch-Jones1 , Frank Kero3 1.Boston University School of Medicine, Boston, MA 2. Maine Health and Environmental Testing Laboratory, Augusta, ME 3. PerkinElmer, Shelton, CT Fig 3. Glass capillary and mesh target screen sample trays for DSA (left). Schematic of DSA ionization source (right). Fig 2. (A) Close-up of mesh target screen sample tray and inlet to AxION TOF MS. (B) DSA ionization source (C) DSA-TOF MS instrument. A B CIntroduction As of March 2016, the Drug Enforcement Administration placed two fentanyl analogs (beta-hydroxythiofentanyl and butyryl fentanyl) under Schedule I due to their imminent threat to public health. These drugs elicit analgesic effects similar to heroin making them desirable drugs to abuse. Novel fentanyl analogs and designer opiates are expected to be more prominent in forensic casework in the near future. These drugs can be seen in forensic casework either alone or can be mixed with other drugs of abuse such as heroin. It is therefore necessary to have an efficient methodology to identify these compounds. Currently, Gas Chromatography-Mass Spectrometry (GC-MS) is used to identify drugs of abuse and is considered the “gold standard” in forensic casework. However, analysis times can often range from 15-60 minutes in length. Another drawback is need for spectral library matching, requiring analytical reference materials for identification, meaning these new designer drugs cannot be identified until a reference material is available. In this study, Direct Sample Analysis Time-of-Flight Mass Spectrometry (DSA-TOF) was utilized to provide rapid identification of fentanyl and related synthetic opiates. DSA is a direct ambient ionization source, requiring no chromatography and minimal sample preparation. High resolution time of flight mass spectrometry generates empirical formula information allowing for substance identification without a reference material. Applying in- source collision-induced dissociation (CID) produces additional structural information for confirmation. The analytes explored in this study include: heroin, 6-MAM, morphine, fentanyl, norfentanyl, acetylfentanyl, butyrylfentanyl, beta- hydroxythiofentanyl, furanylfentanyl, valerylfentanyl, AH-7921, U- 47700, buprenorphine, norbuprenorphine, desomorphine, MT-45, W-15, and W-18. Conclusion •For the screening of synthetic opiates, DSA-TOF was successful at reducing analysis time from minutes to seconds for qualitative analyte identification. • Analysis time was only 20 seconds. •18 opiates and related compounds were evaluated, and in all measurements, mass accuracy was below 5 ppm. •In-source collision-induced dissociation (CID) can be used to generate compound specific fragmentation for further confirmation. •Limit of detection (LOD) was determined to be 0.1 ppm. LOD was determined by analyzing standards at 0.1 ppm, 0.05 ppm, and 0.01 ppm concentrations a minimum of 10 times. At 0.1 ppm, there was only one mass accuracy failure, but no fragment identification failure. At concentrations of 0.05 and 0.01 there was fragment identification failure (signal below 500 counts) over 50% of the time. •Application of this method to a forensic case sample was successful, demonstrating its utility in the forensic laboratory for these types of compounds •TOF allows for both targeted and non-targeted analysis •As designer drugs emerge in communities, TOF methods allow the flexibility to scale methods to include emerging public health threats •TOF allows the user to re-analyze sample data without the need for reinjection •Future Directions: • Exploration of DSA-TOF MS as a rapid method to screen urine samples for opiates • DSA-TOF MS is currently being explored for use in the identification of other street drugs. Compound Formula Error (ppm) Heroin C21H23NO5 0.387 6-MAM C19H21NO4 -4.44 Morphine C17H19NO3 -1.64 Buprenorphine C29H41NO4 -3.11 Norbuprenorphine C25H35NO4 -1.26 Fentanyl C22H28N2O -3.38 Norfentanyl C14H20N2O 4.71 Acetylfentanyl C21H26N2O -0.113 β-hydroxythiofentanyl C20H26N2O2S 1.73 Butyrylfentanyl C23H30N2O -1.3 Furanylfentanyl C24H26N2O2 0.529 Valerylfentanyl C24H32N2O -2.21 AH-7921 C16H22Cl2N2O -3.3 U-47700 C16H22Cl2N2O 0.819 Desomorphine C17H21NO2 -2.47 MT-45 C24H32N2 2.58 W-15 C19H21ClN2O2S -1.26 W-18 C19H20ClN3O4S -4.55 94.0631 105.0699 188.1445 189.1471 281.2007 337.2286 338.2318 0 5000 10000 15000 20000 25000 30000 35000 40000 45000 100 200 300 400 500 Mass GEN (00.09458:00.10791) Amplitude m/z Curve 1 94.0405 105.0684 188.1437 189.1465 322.0484 323.2118 324.2150 0 5000 10000 15000 20000 25000 30000 35000 100 200 300 400 500 Mass GEN (00.11150:00.12150) Amplitude m/z Curve 1 94.0404 121.0497 188.1446 375.2065 376.2096 0 1000 2000 3000 4000 5000 6000 100 200 300 400 500 Mass GEN (00.19458:00.20791) Amplitude m/z Curve 1 105.0712 188.1455 189.1494 351.2435 352.2475 353.2532 0 5000 10000 15000 20000 25000 100 200 300 400 500 Mass GEN (00.08116:00.09791) Amplitude m/z Curve 1 94.0408 105.0438 121.0509 192.0862 210.0945 285.1418 341.1682 359.1782 360.1818 0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000 11000 100 200 300 400 500 Mass GEN (00.19550:00.21216) Amplitude m/z Curve 1 94.0416 121.0509 188.1445 189.1498 365.2596 366.2630 0 2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 22000 100 200 300 400 500 Mass GEN (00.14016:00.16016) Amplitude m/z Curve 1 95.0856 172.9575 174.9546 189.9843 191.9820 284.0625 285.0667 286.0597 287.0611 329.1193 331.1169 0 5000 10000 15000 20000 25000 30000 35000 100 200 300 400 500 Mass RET (00.13750) Amplitude m/z Curve 1 94.0412 121.0509 167.1550 169.1699 181.1015 322.0456 350.2672 0 2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 100 200 300 400 500 Mass GEN (00.14541:00.15541) Amplitude m/z Curve 1 94.0375 121.0509 174.9557 284.0606 285.0620 286.0578 287.0614 0 2000 4000 6000 8000 10000 12000 14000 16000 100 200 300 400 500 Mass GEN (00.13783:00.14783) Amplitude m/z Curve 1 273.0461 392.1215 394.1193 422.0955 423.0988 424.0933 0 1e4 2e4 3e4 4e4 5e4 6e4 7e4 8e4 9e4 10e4 100 200 300 400 500 Mass RET (00.09308) Amplitude m/z Curve 1 105.0710 121.0509 322.0459 377.1090 378.1108 379.1052 380.1089 0 5000 10000 15000 20000 25000 30000 35000 40000 45000 100 200 300 400 500 Mass RET (00.10908) Amplitude m/z Curve 1 377.1090 378.1108 379.1052 380.1089 0 5000 10000 15000 20000 25000 30000 35000 40000 45000 376 377 378 379 380 381 382 Mass RET (00.10908) Amplitude m/z Curve 1 Fig 4. Diagram of a TOF Mass Spectrometer showing the separation of ions of different mass (top). Diagram of a TOF Mass Spectrometer showing how a Reflector improves mass resolution (bottom). 4 0 6 0 8 0 1 0 0 1 2 0 1 4 0 1 6 0 1 8 0 2 0 0 2 2 0 2 4 0 2 6 0 2 8 0 3 0 0 3 2 0 3 4 0 3 6 0 3 8 0 4 0 0 4 2 0 4 4 0 0 5 0 0 0 0 1 0 0 0 0 0 1 5 0 0 0 0 2 0 0 0 0 0 2 5 0 0 0 0 3 0 0 0 0 0 3 5 0 0 0 0 4 0 0 0 0 0 4 5 0 0 0 0 m / z - - > A b u n d a n c e S c a n 2 1 5 2 (1 6 .1 1 1 m in ) : 0 0 6 .D d a ta .m s 2 8 3 . 1 2 4 0 . 1 9 5 . 1 1 5 8 . 14 2 . 2 1 8 7 . 1 3 7 2 . 11 2 8 . 1 3 3 1 . 1 4 0 5 . 2 4 4 5 . 9 4 0 6 0 8 0 1 0 0 1 2 0 1 4 0 1 6 0 1 8 0 2 0 0 2 2 0 2 4 0 2 6 0 2 8 0 3 0 0 3 2 0 3 4 0 3 6 0 3 8 0 4 0 0 4 2 0 0 1 0 0 0 0 2 0 0 0 0 3 0 0 0 0 4 0 0 0 0 5 0 0 0 0 6 0 0 0 0 7 0 0 0 0 8 0 0 0 0 9 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 1 2 0 0 0 0 1 3 0 0 0 0 1 4 0 0 0 0 1 5 0 0 0 0 1 6 0 0 0 0 1 7 0 0 0 0 1 8 0 0 0 0 1 9 0 0 0 0 m / z - - > A b u n d a n c e S c a n 2 1 5 3 ( 1 6 .1 1 7 m i n ) : 0 1 0 C A Y M A N 0 4 7 5 9 9 3 - 3 4 .D d a ta .m s 2 8 3 . 1 2 4 0 . 1 9 5 . 1 1 5 8 . 14 2 . 1 1 3 0 . 1 1 8 7 . 1 3 7 2 . 23 4 1 . 0 4 0 5 . 2 85.0280 105.0683 188.1441 189.1471 322.0487 325.1897 375.2069 376.2092 0 5000 10000 15000 20000 25000 30000 35000 40000 45000 50000 55000 100 200 300 400 500 Mass GEN (00.07450:00.08791) Amplitude m/z Curve 1 375.2069 376.2092 377.2113 0 5000 10000 15000 20000 25000 30000 35000 40000 45000 50000 55000 375 380 385 390 Mass GEN (00.07450:00.08791) Amplitude m/z Curve 1 Fig 1. NFLIS regional trends in fentanyl reported per 100,000 persons aged 15 or older, January 2009 – June 2014 Fig 5. DSA-TOF spectra at 10ppm concentration: a) fentanyl b) acetylfentanyl c)furanylfentanyl d) butyrylfentanyl e) β- hydroxythiofentanyl f) valerylfentanyl g) AH-7921 h) MT-45 i) U-47700 j) W-18 Table 1. Molecular formula and mass accuracy for 18 compounds evaluated in this study. IS Mannitol a b c d e f g h i j Acknowledgements •Maria Pease, Maine HETL Forensic Chemistry Section •Maine Drug Enforcement Agency •David Francis, PerkinElmer, for troubleshooting assistance •Charlie Schmidt and Bill Hahn for continued support References 1.NATIONAL FORENSIC LABORATORY INFORMATION SYSTEM. Special Report: Opiates and Related Drugs Reported in NFLIS, 2009–2014. Office of Diversion Control, DOJ, DEA. 2015 2.Ohta, H.; Suzuki, S.; Ogasawara, K. Journal of Analytical Toxicology 1999, 23, 280–285. 3.Vardanyan, R.; Hruby, V.; Future Med Chem. 2014 March, 6(4), 385-412. 4.Winter, G.; Wilhide, J.; LaCourse, W.; J. Am. Soc. Mass Spectrom. 2015 5.PerkinElmer resources for AxION DSA-TOF Instrumentation PerkinElmer AxION 2 TOF Time of Flight Mass Spectrometer PerkinElmer AxION Direct Sample Analysis module Sample Preparation Standard Solutions: 5 uL of dilute analytical standard was applied directly to the mesh target screen for DSA-TOF analysis. Analytical standards were purchase from Cerilliant Corporation (Round Rock, TX) and Cayman Chemical (Ann Arbor, MI) at a concentration of 1.0 mg/mL in methanol and diluted with LC-MS Grade water (Sigma Aldrich). Solid Samples: A small amount of sample was taken on the tip of a spatula, added to 3 mL of Methanol and vortexed. 5 uL was applied directly to the mesh target screen for DSA-TOF analysis. AxION DSA/TOF MS Instrument Parameters The AxION DSA conditions were as follows: a corona current of 5 µA, heater temperature of 325°C, auxiliary gas (N2) pressure of 80 psi, drying gas (N2) flow of 3 L/min, and drying gas (N2) temperature of 25°C. The AxION 2 TOF MS was run in positive mode with a flight tube voltage of -10,000 V. The capillary exit voltage was set to 175V for MS analysis. Mass spectra were acquired with a mass range of 85-2000 m/z and an acquisition rate of 5 spectra/sec. To maintain mass accuracy, two lock mass ions were used (m/z 121.0509 and m/z 622.0290). All samples were analyzed for only 20 seconds. Fig 6. DSA-TOF spectra of W-15 analytical standard (10 ppm). Fig 7. Close up of DSA-TOF spectra of W-15 [M+H]+ and isotopes. Fig 8. AxION EC ID software determination of molecular formula for W-15 based on mass accuracy, isotope ratios, and isotope spacing. Demonstration using analytical reference material. Fig 14. AxION EC ID software determination of molecular formula for unknown based on mass accuracy, isotope ratios, and isotope spacing. Molecular formula for furanylfentanyl was determined with a mass accuracy of -0.598 ppm. Following TOF analysis, an analytical standard was run on GC-MS for confirmation. Fig 9. TIC from GC-MS analysis of unknown substance. Fig 10. EI-MS spectra of unknown (top). EI-MS spectra of Furanylfentanyl analytical standard (bottom). Fig 12. DSA-TOF spectra of unknown sample. Fig 13. Close up of DSA-TOF spectra of unknown sample [M+H]+ and isotopes. Fig 11. Unknown powder seized by law enforcement in Maine. 349.2629 [M+H]+ 329.1179